Book Image

Live Longer with AI

By : Tina Woods
Book Image

Live Longer with AI

By: Tina Woods

Overview of this book

Live Longer with AI examines how the latest cutting-edge developments are helping us to live longer, healthier and better too. It compels us to stop thinking that health is about treating disease and start regarding it as our greatest personal and societal asset to protect. The book discusses the impact that AI has on understanding the cellular basis of aging and how our genes are influenced by our environment – with the pandemic highlighting the interconnectedness of human and planetary health. Author Tina Woods, founder and CEO of Collider Health and Collider Science, and the co-founder of Longevity International, has curated a panel of deeply insightful interviews with some of today’s brightest and most innovative thought leaders at the crossroads of health, technology and society. Read what leading experts in health and technology are saying about the book: "This is a handbook for the revolution!" —Sir Muir Gray, Director, Optimal Ageing "You can live longer and be happier if you make some changes – that is the theme of this book. Well-written and compelling." —Ben Page, CEO, Ipsos Mori "Tina's book is a must-read for those who want to discover the future of health." —José Luis Cordeiro, Fellow, World Academy of Art & Science; Director, The Millennium Project; Vice Chair, Humanity Plus; Co- Author of The Death of Death About the consultant editor Melissa Ream is a leading health and care strategist in the UK, leveraging user-driven design and artificial intelligence to design systems and support people to live healthier, longer lives.
Table of Contents (8 chapters)
Preface
7
Index

Interviews

The following interviews reflect expertise at the cutting edge of aging: Nir Barzilai, who has convinced the FDA to completely change how it categorizes indications to trial the diabetes drug metformin for its ability to delay aging, the main risk factor for many chronic diseases; Paul Dagum, a pioneer who uses digital biomarkers to help diagnose and manage mental health conditions, which are on the rise as a result of the pandemic; Thomas Balkizas, who combines his Big Tech experience working with Amazon Web Services with the ability to sniff out the next disruptors on the horizon and his perspective as an investor who founded Alpha Tech Capital; Teemu Sanu, founder of Nightingale Health, which uses blood-based molecular data and AI to predict disease risk, aiming to abolish chronic diseases through prevention; and Nicola Palmarini, who was formerly with the behemoth IBM as its head of ethics and aging, and is now director of the National Innovation for Ageing in the UK...